Skip to content
Disclosery

PharVision Advisers, LLC: TKC position timeline

Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of PharVision Advisers, LLC on TKC, newest first. How the timeline and the estimate are built.

PharVision Advisers, LLC held 12,671 TKC shares at 2026-06-30 per its 13F-HR filed 2026-08-11.

the latest 13F is the newest step

  1. period ended2026-06-30
    13F 12,671 shares
    Change vs previous 13F -6,112 shares

    1.4% of the 13F portfolio, value $74,505.

    13F-HR 0001420506-26-001505 filed by PharVision Advisers, LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  2. period ended2026-03-31
    13F/A 18,783 shares
    Change vs previous 13F +299 shares

    1.15% of the 13F portfolio, value $113,262.

    13F-HR/A 0001420506-26-000909 filed by PharVision Advisers, LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  3. period ended2025-12-31
    13F 18,484 shares
    Change vs previous 13F not available

    0.05% of the 13F portfolio, value $101,107.

    13F-HR 0001420506-26-000567 filed by PharVision Advisers, LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).